These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. MEN4, the MEN1 Mimicker: A Case Series of three Phenotypically Heterogenous Patients With Unique CDKN1B Mutations. Seabrook A; Wijewardene A; De Sousa S; Wong T; Sheriff N; Gill AJ; Iyer R; Field M; Luxford C; Clifton-Bligh R; McCormack A; Tucker K J Clin Endocrinol Metab; 2022 Jul; 107(8):2339-2349. PubMed ID: 35323929 [TBL] [Abstract][Full Text] [Related]
10. Multiple endocrine neoplasia, the old and the new: a mini review. Pasquali D; Di Matteo FM; Renzullo A; Accardo G; Esposito D; Barbato F; Colantuoni V; Circelli L; Conzo G G Chir; 2012; 33(11-12):370-3. PubMed ID: 23140918 [TBL] [Abstract][Full Text] [Related]
11. MEN-4 and other multiple endocrine neoplasias due to cyclin-dependent kinase inhibitors (p27(Kip1) and p18(INK4C)) mutations. Georgitsi M Best Pract Res Clin Endocrinol Metab; 2010 Jun; 24(3):425-37. PubMed ID: 20833334 [TBL] [Abstract][Full Text] [Related]
12. The parathyroid/pituitary variant of multiple endocrine neoplasia type 1 usually has causes other than p27Kip1 mutations. Ozawa A; Agarwal SK; Mateo CM; Burns AL; Rice TS; Kennedy PA; Quigley CM; Simonds WF; Weinstein LS; Chandrasekharappa SC; Collins FS; Spiegel AM; Marx SJ J Clin Endocrinol Metab; 2007 May; 92(5):1948-51. PubMed ID: 17299066 [TBL] [Abstract][Full Text] [Related]
16. Clinical Features of Multiple Endocrine Neoplasia Type 4: Novel Pathogenic Variant and Review of Published Cases. Frederiksen A; Rossing M; Hermann P; Ejersted C; Thakker RV; Frost M J Clin Endocrinol Metab; 2019 Sep; 104(9):3637-3646. PubMed ID: 30990521 [TBL] [Abstract][Full Text] [Related]
17. Functional characterization of a rare germline mutation in the gene encoding the cyclin-dependent kinase inhibitor p27Kip1 (CDKN1B) in a Spanish patient with multiple endocrine neoplasia-like phenotype. Malanga D; De Gisi S; Riccardi M; Scrima M; De Marco C; Robledo M; Viglietto G Eur J Endocrinol; 2012 Mar; 166(3):551-60. PubMed ID: 22129891 [TBL] [Abstract][Full Text] [Related]
18. Germline CDKN1B variant type and site are associated with phenotype in MEN4. Halperin R; Arnon L; Nasirov S; Friedensohn L; Gershinsky M; Telerman A; Friedman E; Bernstein-Molho R; Tirosh A Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256846 [TBL] [Abstract][Full Text] [Related]
19. Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review. Chevalier B; Coppin L; Romanet P; Cuny T; Maïza JC; Abeillon J; Forestier J; Walter T; Gilly O; Le Bras M; Smati S; Nunes ML; Geslot A; Grunenwald S; Mouly C; Arnault G; Wagner K; Koumakis E; Cortet-Rudelli C; Merlen É; Jannin A; Espiard S; Morange I; Baudin É; Cavaille M; Tauveron I; Teissier MP; Borson-Chazot F; Mirebeau-Prunier D; Savagner F; Pasmant É; Giraud S; Vantyghem MC; Goudet P; Barlier A; Cardot-Bauters C; Odou MF J Clin Endocrinol Metab; 2024 Jun; 109(7):e1482-e1493. PubMed ID: 38288531 [TBL] [Abstract][Full Text] [Related]
20. Germline CDKN1B/p27Kip1 mutation in multiple endocrine neoplasia. Georgitsi M; Raitila A; Karhu A; van der Luijt RB; Aalfs CM; Sane T; Vierimaa O; Mäkinen MJ; Tuppurainen K; Paschke R; Gimm O; Koch CA; Gündogdu S; Lucassen A; Tischkowitz M; Izatt L; Aylwin S; Bano G; Hodgson S; De Menis E; Launonen V; Vahteristo P; Aaltonen LA J Clin Endocrinol Metab; 2007 Aug; 92(8):3321-5. PubMed ID: 17519308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]